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Abstract
Bacterial colonization occurs in all wounds, chronic or acute, and the break in epithelium integrity that defines
a wound impairs the forces that shape and constrain the microbiome at that site. This review highlights
the interactions between bacterial communities in the wound and the ultimate resolution of the wound or
development of fibrotic lesions. Chronic wounds support complex microbial communities comprising a wide
variety of bacterial phyla, genera, and species, including some fastidious anaerobic bacteria not identified
using culture-based methods. Thus, the complexity of bacterial communities in wounds has historically been
underestimated. There are a number of intriguing possibilities to explain these results that may also provide novel
insights into changes and adaptation of bacterial metabolic networks in inflamed and wounded mucosa, including
the critical role of biofilm formation. It is well accepted that the heightened state of activation of host cells
in a wound that is driven by the microbiota can certainly lead to detrimental effects on wound regeneration,
but the microbiota of the wound may also have beneficial effects on wound healing. Studies in experimental
systems have clearly demonstrated a beneficial effect for members of the gut microbiota on regulation of systemic
inflammation, which could also impact wound healing at sites outside the gastrointestinal tract. The utilization of
culture-independent microbiology to characterize the microbiome of wounds and surrounding mucosa has raised
many intriguing questions regarding previously held notions about the cause and effect relationships between
bacterial colonization and wound repair and mechanisms involved in this symbiotic relationship.
Copyright  2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keywords: bacteria; inflammation; skin; gastrointestinal tract
Received 7 August 2012; Revised 22 September 2012; Accepted 24 September 2012
No conflicts of interest were declared.
Introduction
The host microbiome is the entire collection of
microorganisms that inhabit a host. This includes bac-
teria, archaea, fungi, parasites, viruses, and phages.
In this review, we will focus almost extensively on
the bacterial microbiome. This subset of the micro-
biome is almost exclusively restricted to mucosal sites
during health, ie the surfaces of the body that are
exposed to the outside world. This includes the skin,
gastrointestinal tract, upper airways, oral cavity, and
reproductive tract. However, despite being exposed to
the outside world, the mucosal surfaces exert selective
pressures on the composition of the bacterial micro-
biome. For example, while over 20 bacterial phyla have
been reported for their growth on plant surfaces, only
nine have been identified in the human gut [1,2].
In the context of this review article, a wound will be
defined as a physical break in epithelium integrity and
the subsequent host response to repair this break. Such
a break in epithelium integrity impairs the forces that
shape and constrain the microbiome at that site. Epithe-
lium destruction will result in reduced production of
mucus or lipids, alter anti-microbial peptide expression,
and activate inflammatory cascades. Mucosal surfaces
are exposed to the environment; thus, wounds also offer
an opportunity for non-indigenous microbes to colo-
nize the site, as well as altering the forces that balance
indigenous microbial colonization (Table 1).
The initiation of wound repair normally begins
very quickly after damage and involves well-integrated
iterative steps in tissue regeneration that include the
following [3–5]:
• clotting and coagulation
• secretion of extracellular signal molecules; eg
cytokines, chemokines, growth factors, and
eicosanoids
• leukocyte recruitment and formation of granulation
tissue
• fibroblast activation and proliferation
• formation of new basement membrane and other
extracellular matrix
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Table 1. Wound microbiome bacterial species with known
associations in wound repair
Summary of studies of bacteria
associated with wounds Association
Streptococcus spp.
Higher incidence in chronic diabetic
wounds
Staphylococcus aureus,
Staphylococcus
epidermidis
Higher incidence in chronic diabetic
wounds Colonization can impair
the wound healing process Readily
cultured from wounds
Enterococcus spp. Higher incidence in chronic diabetic
wounds
Peptostreptococcus spp. Higher incidence in chronic diabetic
wounds
Bacteroides spp. Higher incidence in chronic diabetic
wounds
Prevotella spp. Higher incidence in chronic diabetic
wounds
Pseudomonas aeruginosa Higher incidence in chronic diabetic
woundsInoculation into germ-free
mouse wounds leads to accelerated
wound repair (re-epithelialization,
epidermal cell proliferation, and
neo-vascularization) Readily
cultured from wounds
Lactobacillus spp. Induces ERK phosphorylation in the GI
tract, which could regulate cell
migration and epithelium
restitution during wound repair
Lactobacillus reuteri strain
RC-14
Can inhibit colonization of other
species (ie Staphylococcus aureus)
in a strain-specific manner
Escherichia coli Outgrowth in the GI tract can occur in
environments of increased
inflammation due to epithelial
damageReadily cultured from
wounds
Klebsiella pneumoniae Outgrowth in the GI tract can occur in
environments of increased
inflammation due to epithelial
damageNecessary to induce
transmissible spontaneous colitis in
mice
Proteus mirabilis Necessary to induce transmissible
spontaneous colitis in mice
Corynebacteria spp. Readily cultured from wounds
Propionbacteria spp. Readily cultured from wounds, but in
lesser levels than that found in
healthy skin
Neisseria spp. Fastidious and anaerobic bacteria
commonly found in wounds
Campylobacteria spp. Fastidious and anaerobic bacteria
commonly found in wounds
Clostridiaceae Fastidious and anaerobic bacteria
commonly found in wounds
This table highlights microbes with known associations to wound healing that
are discussed in this review.ERK = extracellular signal-regulated kinases; GI =
gastrointestinal.
• new blood vessel growth
• remodelling to restore normal tissue architecture.
The balance between extracellular matrix forma-
tion and degradation is a key step during the normal
wound-healing process and combined with a balance
between proliferation and apoptosis of fibroblasts, is
a major step in determining whether injured tissues
return to their pre-injury state or develop fibrosis. A
recent review by Meneghin and Hogaboam [3] pro-
vides an excellent overview on the role of infectious
agents including bacteria, viruses, fungi, and multicel-
lular parasites in cellular activation and the promotion
of fibrosis (including examples in pulmonary, cardio-
vascular, integumentary, and alimentary systems). This
review will focus on our current understanding of the
role of the bacterial microbiome in mucosal wound
repair pathology.
What is the bacterial microbiome and where is it
found in the body?
Bacteria outnumber host cells by 10 : 1 and the
metagenome of the bacterial microbiome is 100
times larger in size than the host genome [6].
Culture-independent methods have revealed a much
greater diversity within the bacterial communities on
the mucosa than previously identified by traditional
culture-based methods [2,6]. The four most dominant
phyla in the human body are the Firmicutes, Bac-
teroidetes, Proteobacteria, and Actinobacteria. How-
ever, the relative distributions of these four phyla differ
vastly between body sites. For example, Firmicutes
and Bacteroidetes are the most abundant members in
the gastrointestinal tract [2,6], while Proteobacteria and
Actinobacteria dominate the skin [1] and Proteobacte-
ria appear to be significant members of the airways
[7–11]. Furthermore, the density of the indigenous
microbiota differs along the mucosa, with the highest
concentration and diversity being found in the large
intestine.
Metabolic, immunological, secretory, and structural
forces shape the bacterial communities of the mucosa
[1,2,6,12] (summarized in Figure 1). Diet and nutrient
availability are two major factors that modulate bacte-
rial growth. Polymicrobial communities naturally form
complex, three-dimensional aggregates called biofilms,
which create metabolic webs of agonistic and antag-
onistic relationships among its membership [13,14].
Host defence/immunity also plays an important role
in creating specific niches for bacterial colonization
through the production of anti-microbial peptides,
secretory immunoglobulins, and bactericidal effector
mechanisms activated through mucosal damage [12].
Other secretory mechanisms important in modulating
bacterial community structure include the production
of mucus, surfactants, and specific lipids. All of these
forces are in play on the smooth and involuted mucosal
surfaces that are also subject to one or more of the fol-
lowing structural forces, depending on the body site:
physical abrasion; peristaltic movement of solids and
liquid; ciliary movement of mucus; epithelium stretch;
and gradients of pH, temperature, and/or oxygen con-
centration.
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Figure 1. Summary of the mechanisms involved in modulating the bacterial microbiome of wounds and the effects of different wound
microbiomes on the inflammatory and healing process. Specific details of the processes outlined in this figure are described in the text.
ROS = reactive oxygen species; TLR = toll-like receptor.
How do you analyse the microbiome?
The adaptation of recently developed, high-throughput
molecular approaches to culture-independent microbi-
ology, such as 16S rRNA gene-based pyrosequencing,
is beginning to provide new insight into identifying
and understanding the role of bacterial communities
in the processes of wound repair, chronic wound for-
mation, and fibrosis. Of note are the recent numerous
reports that chronic wounds support complex microbial
communities consisting of a wide variety of bacterial
phyla, genera, and species, including some fastidious
anaerobic bacteria not identified using culture-based
methods [15–18]. The key limitation of culture-based
methodologies is the inability to routinely grow out
these fastidious and/or currently ‘unculturable’ organ-
isms. Estimates are that more than 60% of bacte-
rial species in the human microbiome have not been
able to be cultured and a majority of the remaining
bacteria have complex and dynamic growth require-
ments, rendering them difficult to reproducibly isolate
[19]. Most commonly, culture-independent techniques
are based on PCR amplification of the 16S rRNA
gene. This gene is relatively small (approximately 1.5
kbp), highly conserved, not subject to natural selec-
tion pressures, and transmitted vertically without lateral
gene transfer. It possesses nine hypervariable regions
(V1–9) in which the vast majority of evolutionary
changes have occurred, rendering this single gene use-
ful for taxonomic identification [20]. Databases are
available that encompass more than 500 000 16S rRNA
sequences from a range of phylotypically diverse bacte-
ria. Conserved sequence stretches within the 16S rRNA
gene allow for the design of broad bacterial kingdom-
specific primers, which can be used to create amplicons
of individual 16S rRNA genes derived from a mixed
bacterial population. High-throughput sequencing of
these 16S rRNA gene amplicon libraries is possible,
with the most powerful being 454-pyrosequencing, due
to sequence read lengths of over 400 bp (sufficient to
cover at least two adjacent 16S rRNA hypervariable
regions) and output of greater than 106 high-quality
sequence reads [21–23], permitting a rapid robust sam-
pling of microbial communities [24–28].
What is the microbiome in sites of acute
resolving, acute non-resolving, and chronic
(non-resolving) wounds?
Bacterial colonization occurs in all wounds, chronic
or acute. One area of active investigation is under-
standing the correlation between different microbial
communities in the wound and the ultimate repair of
the wound (versus the development of chronic wounds
and/or fibrotic lesions). Chronic wounds often contain
higher levels of culturable bacteria compared with heal-
ing wounds, and experimental colonization of wounds
can delay healing [29,30]. Bacterial colonization of
wounds is polymicrobial [15–17,31,32] and in the form
of a biofilm [32–34]. Antibiotics typically do not ster-
ilize wounds (even broad spectrum antibiotics) because
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bacterial cells in biofilms have increased resistance to
biocides [35]. However, antibiotics can shift the growth
balance in bacterial community composition, prevent-
ing pathogenic bacterial colonization that can lead to
enhanced tissue damage and/or systemic dissemina-
tion of pathogenic bacteria. Despite this, published
research does not support a positive effect of antibi-
otic therapy for chronic wound healing [36]. Antibi-
otic use for chronic wounds is often associated with
selection for more resistant bacterial species. Many
Pseudomonas species are extremely adept at adapting
to antibiotic pressure, and certain antibiotics appear to
actually induce the formation of pseudomonal biofilms,
perhaps accounting for the increased colonization of
chronic wounds by Pseudomonadaceae [15,37].
A number of groups have used culture-independent
methods to analyse bacterial wound communities and,
collectively, these groups have reported the follow-
ing observations about the microbiota of wounds
[15–18,31,32]. First, the number and proportion of
bacterial species can range greatly between individ-
ual wounds. Second, bacterial diversity as determined
by culture-based methods is significantly lower than
that obtained through 16S rRNA gene-based ampli-
con pyrosequencing. Thus, the complexity of bac-
terial communities in wounds has historically been
underestimated. Commonly isolated organisms include
Staphylococcus , Corynebacterium , and Propionibac-
terium (although Propionibacterium species are typ-
ically found at lower levels in wounds compared with
healthy skin). Notable on the list of wound bacteria
are the fastidious and/or anaerobic organisms Neis-
seriaceae, Campylobacteriaceae, and Clostridiaceae.
Proteobacteria are commonly identified in wounds and
largely belong to the Pseudomonadaceae, Enterobac-
teriaceae, Oxalobacteraceae, and Neisseriaceae fam-
ilies. Additional work needs to be done to identify
many of these non-culturable organisms at the species
level. Third, the microbiota can differ between different
wounds, while bacterial communities at different sites
within an individual wound are significantly more sim-
ilar to each other than to those from different wounds
[17,38]. Finally, the reliability of both culture- and non-
culture-based analysis depends heavily on the sampling
method used. For example, certain sampling techniques
will not detect anaerobic bacteria, which are common
in chronic wounds [39]. Therefore, when studying the
human microbiome, important controls need to be in
place to guarantee that the chosen sampling techniques
are as unbiased and comprehensive as possible.
Diabetic wounds are well documented to display
defects in the steps involved in normal wound heal-
ing, resulting in chronic wounds. Colonization of dia-
betic versus non-diabetic wounds is also markedly
different, including an increased incidence of colo-
nization by Streptococcus or Staphylococcus in dia-
betic wounds [17]. Other commonly cultured bacteria
from non-healing diabetic wounds include Staphylo-
coccus aureus , S. epidermidis , Pseudomonas aerug-
inosa , Enterococcus spp., Peptostreptococcus spp.,
Bacteroides spp., and Prevotella spp. [40–42]. Col-
onization of wounds by Staphylococcus likely impairs
wound healing, as supported by both clinical associa-
tive data and experimental animal models, including
reports that colonization of wounds in mice can prevent
re-growth of the epithelium and the aberrant inflam-
matory response in the skin of diabetic db/db mice
promotes colonization by Staphylococcus [40,43–47].
Surprisingly, many of these studies are finding
readily-culturable bacteria by culture-independent
methods that are otherwise not being identified by
traditional culture-based methods [15–17,31,32].
Cultivation relies heavily on selective media and
can mask the presence of less numerous organisms.
However, beyond the obvious devil’s advocate answer
that these bacteria are actually dead (which evidence
from a variety of sources is rendering unlikely), there
are a number of intriguing possibilities to explain
these results that may also provide novel insights
into changes and adaptation of bacterial metabolic
networks in inflamed and wounded mucosa. Within
biofilms, the precipitous oxygen gradients that form
microaerophilic and anaerobic regions, combined with
increased gene flow among biofilm members, lead to
metabolic alteration of bacterial cells [48,49]. Species
known to readily grow on standard laboratory media
will no longer exhibit typical phenotypes, some-
times leading to non-culturability. This phenomenon
has been heavily researched in Pseudomonadaceae
biofilms. For example, Pseudomonas species isolated
from clinical chronic biofilms will commonly exhibit a
loss of motility [50], amino acid auxotrophy [51], lack
of type III secretion and siderophore production [52],
and a long list of other loss-of-function mutations
[53]. There is also a robust line of investigation
in understanding the mechanisms that regulate the
viable-but-not-culturable (VBNC) state, where bacteria
cease to multiply but remain metabolically active [54],
and this may be relevant to the lifestyle of wound
bacteria.
In microbial communities, both bacterial competition
and cooperation will have an impact on the patho-
physiology of the host. One example of cooperation
that leads to increased virulence involves siderophore-
producing bacteria, such as P. aeruginosa , that are
able to ‘share’ the production of iron-scavenging
siderophores with non-siderophore producers [55]. A
heterogeneous population of siderophore producers and
non-siderophore-producing bacteria can lead to higher
levels of bacterial growth. The evolution of such
iron ‘cheats’ occurs more readily in low-iron condi-
tions, revealing how the host environment shapes such
microbial cooperation [56]. It should be noted that
sequestration of free iron is a major mechanism of
innate immunity [57,58]. However, inter-species bac-
terial competition also plays a role in mixed bacterial
populations. For example, P. aeruginosa can lyse other
bacterial species, such as S. aureus , and utilize the bac-
terial lysate as a source of free iron, thereby increasing
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its ability to colonize under iron-limited conditions of
the host [59,60].
As an additional illustration of potential
bacteria–bacteria antagonism in a wound, it has
been demonstrated that Lactobacillus reuteri strain
RC-14 can inhibit Staphylococcus aureus infection in
a rat surgical-implant model [61]. In this study, a small
sterile piece of silicone was inserted subcutaneously
and inoculated with L. reuteri and/or S. aureus . The
surgical incisions were then sutured and abscess
formation was followed. Implantation of lactobacillus
alone did not induce any abscess formation and
the addition of the lactobacilli prevented abscess
formation induced by S. aureus . This was not true
for all the lactobacillus strains tested, suggesting
a strain-specific mechanism, which may involve a
secreted cell-signalling molecule [62]. Many other
examples exist in the literature of competing bacteria
interfering with quorum-sensing pathways, bacteriocin
production, and virulence factor production. It remains
to be determined whether such mechanisms shape the
bacterial microbiome of wounds.
What is the effect of changing the localized
microbiome on wound repair?
Microbial colonization or infection is hypothesized to
play an important role in driving chronic inflamma-
tion, chronic wounds, and the development of fibrosis
[3,5,63] (summarized in Figure 1). Pulmonary tuber-
culosis is one example of a chronic disease that is
characterized by bacterially-induced chronic fibrosis.
In this disease, there are significant numbers of acti-
vated M2 macrophages and fibroblasts in Mycobac-
terium tuberculosis-containing granulomas [64]. These
macrophages express TLRs that when activated with
the appropriate bacterial PAMPs stimulate T cells to
produce cytokines and chemokines that promote a
fibrotic response. Activated M2 macrophages are also
found at sites of wound repair in chronic non-resolving
wounds; thus, it seems likely that the microbial pop-
ulations that colonize these wounds can significantly
influence the activation and signal production by these
macrophages (reviewed in refs 3 and 5). In addition to
leukocytes, myofibroblasts also express many TLRs,
including TLRs 2–7. Stimulation of these TLRs can
lead to the production of chemokines and cytokines,
including CXC chemokine ligand 8 (CXCL8/IL-8),
which has neutrophil chemotactic activity as well
as being a pro-angiogenesis molecule. Bacterial CpG
stimulation of TLR9 can also drive interstitial fibrotic
pathways. Primary fibroblasts from sites of inflam-
mation have also been demonstrated to release large
amounts of other CXC and CC chemokines including
CCL5, CCL8, and CXCL6. Thus, stimulation of TLRs
by PAMPs released by the microbiota of wounds may
play a role in maintaining leukocytes and myofibrob-
lasts in a heightened state of activation.
The heightened state of activation of host cells in a
wound that is driven by the microbiota can certainly
lead to detrimental effects on wound regeneration, but
the microbiota of the wounds may also have benefi-
cial effects on wound healing. For example, wound
healing following surgical skin incision and suture was
followed in germ-free and conventionalized mice [65].
The conventional mice showed greater tensile strength
of the wound initially, including higher hydroxyproline
concentration in the surrounding tissue, than the germ-
free mice. In another study, of dermal wounding in rats,
inoculation of wound sites with P. aeroginosa PA01
accelerated re-epithelialization, epidermal cell prolif-
eration, and neo-vascularization, as well as the local
infiltration of neutrophils and TNF production [66].
Treatment of these rats with antibodies against neu-
trophils or TNF caused a significant reduction in the
wound healing response. Other experimental studies
have demonstrated a similar positive effect of low-level
wound colonization, even by potentially pathogenic
microbes, depending on the level of colonization and
type of wound [67–69]. While these examples sug-
gest local benefits of the microbiota on wound heal-
ing, other studies in experimental systems have clearly
demonstrated a beneficial effect for members of the
gut microbiota on regulation of systemic inflammation
[70,71], which could impact wound healing at sites
outside the gut.
Could changes in the gastrointestinal microbiome
affect local epithelium repair?
The gastrointestinal (GI) epithelium is constantly
undergoing wounding and repair. The process of repair-
ing small gaps, ie a few individual epithelial cells,
within the epithelial layer of the GI tract is known
as epithelial restitution [72]. This process involves a
highly localized response in the adjacent epithelium,
while losses of larger contiguous epithelium regions
(> 10 cells) stimulate a more robust repair response,
analogous to skin wound repair, and involve cell types
present in the lamina propria, including leukocytes,
fibroblasts, and subepithelial myofibroblasts.
The mechanisms by which the resident microbiota
influences restitution and the wound repair response of
the GI epithelium are areas of active investigation [73].
Gastrointestinal restitution is modulated by numerous
host factors; however, the indigenous microbiota also
plays a role (positive and/or negative) in modulating
the GI restitution response, such as through the pro-
duction of short-chain fatty acids and modification of
bile acids. Epithelial cells of the GI tract express mul-
tiple TLRs on both their basolateral and their apical
surfaces, as well as intracellular TLRs that recognize
bacterial PAMPs. The requirement for TLR-mediated
signalling in the GI repair response is illustrated in a
study of DSS-induced colitis [74]. In this study, acute
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GI epithelial damage and inflammation were aggra-
vated in TLR2−/−, TLR4−/−, and MyD88−/− mice,
confirming the key role of microorganisms and micro-
bial products in GI repair.
Epithelial restitution requires active cell migration,
a process dependent on a constant turnover of focal
cell–matrix adhesions (FAs). In a recent study, it
was demonstrated that enteric resident bacteria can
potentiate epithelial restitution via the generation of
reactive oxygen species (ROS) in epithelial cells, which
in turn mediates inactivation of focal adhesion kinase
phosphatases [75]. ROS generation induced oxidation
of target cysteines in the redox-sensitive tyrosine
phosphatases LMW-PTP and SHP-2, which in turn
resulted in increased phosphorylation of focal adhesion
kinase (FAK), a key protein regulating the turnover
of FAs. Phosphorylation of FAK substrate proteins,
focal adhesion formation, and cell migration were all
significantly enhanced by bacterial contact in both in
vitro and in vivo models of wound closure.
Microbiota–host epithelial cell interactions can also
modulate β-catenin signalling, a key component in reg-
ulating epithelial cell proliferation [76]. Enteric bacte-
ria can inhibit the NF-κB pathway through the blockade
of IκB-α ubiquitination, a process catalysed by the E3-
SCF(β-TrCP) ubiquitin ligase. The activity of this ubiq-
uitin ligase is regulated via covalent modification of the
Cullin-1 subunit by the ubiquitin-like protein NEDD8,
and it is reported that the interaction of viable indige-
nous bacteria with mammalian intestinal epithelial cells
can result in rapid and reversible generation of ROS
in epithelial cells that modulate neddylation of Cullin-
1 and suppression of the NF-κB pathway [77]. The
short-chain fatty acid and bacterial fermentation prod-
uct butyrate has also been shown to influence epithelial
signalling via ROS-mediated changes in Cullin-1 ned-
dylation [78]. Treatment of human intestinal epithe-
lia in vitro and human tissue ex vivo with butyrate
can cause a loss of neddylated Cul-1 and modulate
the ubiquitination and degradation of a target of the
E3-SCF(β-TrCP) ubiquitin ligase, the NF-κB inhibitor
IκB-α.
A number of indigenous bacterial species have also
been demonstrated to induce ERK phosphorylation
without stimulating pro-inflammatory phospho-IκB or
pro-apoptotic phospho-c-Jun NH2-terminal kinase [79].
Of interest was the observation that Lactobacillus
species have very potent activity. Whole bacterial cell
signalling has also been recapitulated in experimental
studies of epithelial cells using the bacterial peptide
N -formyl-Met-Leu-Phe (N-fMLP) through the formyl
peptide receptors (FPRs). This induction of extracellu-
lar signal-regulated kinase pathway signalling occurred
via FPR-dependent redox modulation of dual specific
phosphatase 3 [80]. The indigenous microbiota could
initiate ERK signalling through rapid FPR-dependent
ROS generation and subsequent modulation of MAP
kinase phosphatase redox status. Epithelial ROS gen-
eration induced by Lactobacillus rhamnosus GG and
N-fMLP could be abolished in the presence of selective
inhibitors for G protein-coupled signalling and FPR
ligand interaction. Inhibitors of ROS generation could
attenuate microbiota-induced ERK signalling, impli-
cating ROS generation in ERK pathway activation.
Altogether, the studies described in the last few para-
graphs raise the possibility that normal members of the
bacterial microbiome stimulate the generation of ROS
in intestinal epithelial cells through FPR-mediated sig-
nalling that modulates the ERK pathway, which in turn
regulates epithelial cell migration and epithelium resti-
tution.
The indigenous microbiota can also promote wound
pathology. For example, indomethacin-induced gastric
ulceration in rats is dependent on the presence of a
microbiota [81]. Treatment of rats with indomethacin
also changes their microbiome [82], implicating a rela-
tionship between mucosal inflammation and micro-
biome community structure. This concept is supported
by other studies of gastrointestinal inflammation in
which mucosal inflammation and epithelium damage
drive changes in the indigenous microbiota, resulting in
the outgrowth of γ-proteobacteria, such as E. coli and
Klebsiella pneumoniae [83,84]. In a model of trans-
missible spontaneous colitis in mice, the transmissible
bacterial community required the presence of K. pneu-
moniae and P. mirabilis in that community for mucosal
inflammation [85]. Outgrowth of γ-proteobacteria in
the GI microbiota appears to be a general ecological
phenomenon of a disturbed microbiome [86]. Thus,
wounded epithelium appears to provide a selective
niche for chronic colonization by γ-proteobacteria,
as well as other bacteria in a polymicrobial biofilm
[32–34], which in turn may drive inflammatory and
fibrogenic processes that are detrimental to controlled
wound repair and tissue regeneration.
Conclusion
The utilization of culture-independent microbiology
to characterize the microbiome of wounds and sur-
rounding mucosa has raised many intriguing questions
regarding previously held notions about the cause and
effect relationships and mechanisms involved. Micro-
bial colonization or infection is hypothesized to play
an important role in driving chronic inflammation and
the development of fibrosis, while inflammation itself
can alter microbial colonization. Percival et al . have
recently discussed two possible hypotheses to explain
the role of bacteria in non-healing chronic wounds
[87]. In both of these hypotheses, wounds naturally
have bacterial biofilms that form and only when the
environmental balance within the wound’s microbiota
changes (due to alterations in host immune response,
local pH, temperature, wound dressings, anti-microbial
treatment, etc.) do these biofilms lead to infection.
The first of these hypotheses is the ‘specific bacterial
hypothesis’, which states that only a few select species
of bacteria break away from the polymicrobial biofilms,
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cause infection, and lead to delayed wound healing.
The second, ‘non-specific bacterial’ or ‘community’
hypothesis, states that it is the overall composition of
the biofilms that creates a pathogenic bacterial com-
munity and leads to infection and delays in wound
healing [87].
Examples of areas of active investigation into the
role of the microbiome in wound repair in the lungs
include diseases such as interstitial pulmonary fibrosis,
chronic obstructive pulmonary disease (COPD), cystic
fibrosis, and asthma [9–11,88]. In the gastrointestinal
tract, normal members of the microbiota, especially
lactobacilli and butyrate-producing bacteria, promote
epithelial repair. Are there also locally resident bacteria
that promote wound repair in the skin and lungs? What
about sterile sites, such as the heart or liver? Could
there be effects of the mucosal microbiome on wound
repair of these non-mucosal sites? The study of the
microbiome as a metabolically active ‘organ’ [89–92],
which can have local and systemic effects on wound
repair and fibrosis, has only just begun.
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